These assumptions are confirmed by Yu MX, et al., that, by exploiting data mining and network pharmacology, showed that the molecular mechanisms of PF secondary to COVID-19 are mainly related to the TNF signaling pathway, the cytokine-cytokine receptor interaction pathway and the NF-κB signaling pathway. Here, NFKB1 is linked to COVID-19.